Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

Share Price is delayed by 15 minutes
Get Live Data
317.50    0.50 (0.16%)
Bid:
315.50
Ask:
317.00
Spread: 1.50 (0.475%)
Market Cap: £732.37m
CSN Live PriceLast checked at - London Stock Exchange

Intraday Chesnara Share Chart

Director/PDMR Shareholding

26 Nov 2021 13:00

RNS Number : 7435T
Chesnara PLC
26 November 2021
 

CHESNARA plc

("Chesnara" or "the Company")

 

26 November 2021

 

LEI Number: 213800VFRMBRTSZ3SJ06

 

 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS / PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY ('PDMRs')

 

Further to the appointment of Steve Murray as Group Chief Executive on 19 October 2021, Chesnara plc (the 'Company') today announces that, under the terms of his appointment, Steve (a PDMR) was granted awards in the ordinary shares of the Company under the Chesnara plc 2014 Long-Term Incentive Scheme to compensate him for remuneration arrangements forfeited on leaving his former employer, The Royal London Mutual Insurance Society Limited. These awards were made in accordance with the Company's Directors' Remuneration Policy and are subject to the Executive Directors' Minimum Shareholding Policy.

 

The notification below, which is being made in accordance with the requirements of Article-19 of the EU Market Abuse Regulation 596/2014 as retained in UK law by virtue of the European Union (Withdrawal) Act 2018, provides further detail of the awards granted.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

b)

Natural person:

Legal person

Steven Grant Murray

2

Reason for the notification

a)

Position/status:

Executive Director and Group Chief Executive

b)

Initial notification/amendment

Initial notification

3

Details of the Issuer

a)

Name

Chesnara plc

b)

Legal Entity Identifier:

213800VFRMBRTSZ3SJ06

4

Details of the transaction(s): Parts a-d of this section are to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)

Description of the financial instrument, type of instrument (Identification code)

Chesnara plc Ordinary Shares of 5 pence each

(GB00B00FPT80)

b)

Nature of the transaction

GRANT 1

Granted under the Chesnara 2014 Long-term Incentive Scheme. The option is subject to a performance target ending 31 December 2021.

 

Subject to the achievement of the performance target, the option will become exercisable on 31 December 2021 and remain exercisable up to and including 26 November 2031 if not exercised before that date.

 

GRANT 2

Granted under the Chesnara 2014 Long-term Incentive Scheme. The option is subject to a performance target ending 31 December 2021.

 

Subject to the achievement of the performance target, the option will become exercisable on 30 June 2022 and remain exercisable up to and including 26 November 2031 if not exercised before that date.

 

GRANT 3

Granted under the Chesnara 2014 Long-term Incentive Scheme. The option is subject to a performance target ending 31 December 2022.

 

Subject to the achievement of the performance target, the option will become exercisable on 31 December 2022 and remain exercisable up to and including 26 November 2031 if not exercised before that date.

GRANT 4

Granted under the Chesnara 2014 Long-term Incentive Scheme. The option is subject to performance targets ending 31 December 2022.

 

Subject to the achievement of the performance target, the option will become exercisable on 30 April 2023 and remain exercisable up to and including 26 November 2031 if not exercised before that date.

 

GRANT 5

Granted under the Chesnara 2014 Long-term Incentive Scheme. The option is subject to performance targets ending 30 June 2023.

 

Subject to the achievement of the performance target, the option will become exercisable on 30 June 2023 and remain exercisable up to and including 26 November 2031 if not exercised before that date.

 

GRANT 6

Granted under the Chesnara 2014 Long-term Incentive Scheme. The option is subject to performance targets ending 31 December 2023.

 

Subject to the achievement of the performance target, the option will become exercisable on 30 April 2024 and remain exercisable up to and including 26 November 2031 if not exercised before that date.

 

GRANT 7

Granted under the Chesnara 2014 Long-term Incentive Scheme. The option is subject to performance targets ending 31 December 2023.

 

Subject to the achievement of the performance target, the option will become exercisable on 30 June 2024 and remain exercisable up to and including 26 November 2031 if not exercised before that date.

 

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

GRANT 1

50,456 Ordinary shares of 5p each

Nil

GRANT 2

119,089 Ordinary shares of 5p each

Nil

GRANT 3

50,456 Ordinary shares of 5p each

Nil

GRANT 4

119,089 Ordinary shares of 5p each

Nil

GRANT 5

20,722 Ordinary shares of 5p each

Nil

GRANT 6

140,105 Ordinary shares of 5p each

Nil

GRANT 7

33,625 Ordinary shares of 5p each

d)

Aggregated information

- Aggregated volume

- Price

 

- 533,542 ORDINARY SHARES OF 5P EACH

- Nil

e)

Date of the transaction (YYYY - MM - DD)

2021-11-26

f)

Place of the transaction

XOFF

 

 

Name of authorised official of issuer responsible for making notification: - Al Lonie

 

Date of notification: - 26 November 2021

 

For further information, please contact:

 

Roddy Watt

Director, Capital Markets

FWD

Forward thinking communications

 

T - 020 7280 0651

E - roddy.watt@fwdconsulting.co.uk 

 

 

Notes to Editors

Chesnara is a life and pensions company listed on the London Stock Exchange. It administers approximately 900,000 policies and operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands, and as Movestic in Sweden.

 

Following a three-pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing profitable new business in Sweden and the Netherlands and by undertaking value-adding acquisitions of either companies or portfolios.

 

Consistent delivery of the Company strategy has enabled Chesnara to increase its dividend for 17 years in succession.

 

Further details are available on the Company's website (www.chesnara.co.uk).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPPGBPGUPGGUQ
Date   Source Headline
10th Aug 201511:22 amRNSNotice of Results
20th May 20157:00 amRNSAcquisition
15th May 201511:56 amRNSResult of AGM
11th May 20154:17 pmRNSRegulatory Approval
28th Apr 20153:40 pmRNSDirector/PDMR Shareholding
27th Apr 20159:51 amRNSAnnual Financial Report
15th Apr 20157:00 amRNSAnnual Report and Accounts and Notice of AGM
31st Mar 20157:00 amRNSFinal Results
9th Mar 20158:48 amRNSNotice of Results
25th Feb 20159:29 amRNSHolding(s) in Company
21st Jan 20154:01 pmRNSDirector/PDMR Shareholding
5th Dec 20147:00 amRNSRegulatory Approval
4th Dec 201412:30 pmRNSPart VII Transfer Approval
3rd Dec 201412:58 pmRNSResults of Placing
3rd Dec 20147:01 amRNSProposed Acquisition and Placing
3rd Dec 20147:00 amRNSDirectorate Change
19th Nov 20147:00 amRNSInterim Management Statement
7th Nov 201412:54 pmRNSTotal Voting Rights
4th Nov 201410:18 amRNSDirector/PDMR Shareholdings / Total Voting Rights
9th Sep 20142:39 pmRNSHolding(s) in Company
29th Aug 20147:00 amRNSHalf Yearly Report
11th Aug 20144:01 pmRNSNotice of Results
21st Jul 201411:42 amRNSTotal Voting Rights
7th Jul 20141:41 pmRNSContract with HCL
19th Jun 20142:06 pmRNSDirectorate Change
20th May 20142:43 pmRNSDirector/PDMR Shareholding
19th May 20147:00 amRNS1st Quarter Results
16th May 201411:40 amRNSResult of AGM
28th Apr 201411:42 amRNSAnnual Financial Report
14th Apr 201412:26 pmRNSAnnual Report and Accounts and Notice of AGM
28th Mar 20141:28 pmRNSDirector/PDMR Shareholding
28th Mar 20147:01 amRNSFinal Results
10th Mar 201412:00 pmRNSNotice of Results
3rd Feb 201411:41 amRNSHolding(s) in Company
21st Jan 20141:56 pmRNSHolding(s) in Company
16th Jan 201410:27 amRNSHolding(s) in Company
28th Nov 20132:00 pmRNSAcquisition
19th Nov 20137:00 amRNS3rd Quarter Interim Management Statement
7th Nov 201311:55 amRNSResult of Meeting
22nd Oct 20135:30 pmRNSStatement re: Posting Circular to Shareholders
8th Oct 20137:00 amRNSSale of Direct Line Life & proposed capital return
8th Oct 20137:00 amRNSAcquisition
30th Aug 20137:00 amRNSHalf Yearly Report
12th Aug 20139:42 amRNSNotice of Results
31st Jul 20139:15 amRNSTotal Voting Rights
4th Jul 201310:10 amRNSListing Rule 9.6.14
28th Jun 20139:01 amRNSTotal Voting Rights
11th Jun 20138:30 amRNSDirectorate Change
22nd May 20133:59 pmRNSHolding(s) in Company
17th May 201311:37 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.